Suppr超能文献

短链低聚果糖尽管在大肠上部被发酵,但在三硝基苯磺酸(TNBS)诱导的结肠炎模型中具有抗炎活性。

Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis.

作者信息

Lara-Villoslada Federico, de Haro Oscar, Camuesco Desire, Comalada Mónica, Velasco Javier, Zarzuelo Antonio, Xaus Jordi, Galvez Julio

机构信息

Department of Biomedicine, PULEVA BIOTECH, S.A., Camino de Purchil no. 66, 18004 Granada, Spain.

出版信息

Eur J Nutr. 2006 Oct;45(7):418-25. doi: 10.1007/s00394-006-0610-2. Epub 2006 Jul 26.

Abstract

Previous studies have demonstrated the anti-inflammatory effect of fructooligosaccharides (FOS) on intestinal inflammation. The aim of the present study was to elucidate whether the colonic fermentation of these carbohydrates is a pre-requisite for this anti-inflammatory activity.With this aim short chain-FOS (SC-FOS) were used for an in vitro fermentation to elucidate the time of fermentation of these compounds. For the in vivo experiments female Wistar rats were fed several diets with different sources of fibre (5 g/kg): cellulose for control rats (n = 30) or SC-FOS (n = 20) with a high content of kestose (GF(2)) for the SC-FOS group. After one month of feeding the different diets 10 rats from each group were sacrificed to analyze cecal and colonic microflora, SCFA production and pH of intestinal contents. A distal colonic inflammation was induced to other 10 rats from each group by the administration of 10 mg of TNBS dissolved in 0.25 ml of 50% ethanol (v/v). The rest of the rats from the control group (n = 10) were rendered healthy. One week after TNBS treatment rats were sacrificed and several inflammatory parameters as well as intestinal microbiota and SCFA contents were analyzed. In vitro fermentation experiments showed that SC-FOS are fermented during the first 12 h after incorporating the oligosaccharides to intestinal contents, thus suggesting a preferential fermentation of these carbohydrates in the ileum and cecum. In fact, SC-FOS increased cecal lactobacilli and bifidobacteria counts as well as SCFA production in healthy rats. In colitic rats, SC-FOS feeding caused a decrease of MPO activity, leukotriene B4 (LTB4) production and iNOS expression. This anti-inflammatory effect was evidenced macroscopically by a significant reduction in the extent of colonic damage. SC-FOS also promoted a more favorable intestinal microbiota, increasing lactobacilli and bifidobacteria counts. In conclusion, although oligosaccharides are preferentially fermented in the upper parts of the large intestine, its prebiotic effect is extended to the distal colonic segments, thus exerting a positive effect on colonic inflammation.

摘要

先前的研究已经证明了低聚果糖(FOS)对肠道炎症的抗炎作用。本研究的目的是阐明这些碳水化合物的结肠发酵是否是这种抗炎活性的先决条件。为此,使用短链低聚果糖(SC-FOS)进行体外发酵,以阐明这些化合物的发酵时间。在体内实验中,给雌性Wistar大鼠喂食几种含有不同纤维来源的日粮(5 g/kg):给对照大鼠(n = 30)喂食纤维素,给SC-FOS组(n = 20)喂食含有高含量潘糖(GF(2))的SC-FOS。在喂食不同日粮一个月后,每组处死10只大鼠,分析盲肠和结肠微生物群、短链脂肪酸(SCFA)的产生以及肠内容物的pH值。通过给每组另外10只大鼠腹腔注射溶解于0.25 ml 50%乙醇(v/v)中的10 mg三硝基苯磺酸(TNBS),诱导远端结肠炎症。对照组其余的大鼠(n = 10)保持健康状态。TNBS处理一周后,处死大鼠并分析几个炎症参数以及肠道微生物群和SCFA含量。体外发酵实验表明,将低聚糖加入肠内容物后的最初12小时内SC-FOS会发生发酵,这表明这些碳水化合物在回肠和盲肠中优先发酵。事实上,SC-FOS增加了健康大鼠盲肠中乳酸杆菌和双歧杆菌的数量以及SCFA的产生。在结肠炎大鼠中,喂食SC-FOS导致髓过氧化物酶(MPO)活性、白三烯B4(LTB4)的产生和诱导型一氧化氮合酶(iNOS)表达降低。这种抗炎作用在宏观上表现为结肠损伤程度的显著降低。SC-FOS还促进了更有利的肠道微生物群,增加了乳酸杆菌和双歧杆菌的数量。总之,尽管低聚糖在大肠上部优先发酵,但其益生元作用扩展到远端结肠段,从而对结肠炎症产生积极影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验